Articles from Enhabit, Inc.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit’s 2025 annual meeting of stockholders.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it’s a great place to work, which is 26 points higher than the average U.S. company.

On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health’s former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting “the egregious breaches of the duty of loyalty” by Anthony, James, and Walker.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference.

Enhabit, Inc. (NYSEEHAB), (“Enhabit”), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon’s appointment follows the previously announced transition of Crissy Carlisle, CFO.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its recognition by the Institute for Healthcare Improvement (IHI) as an Age-Friendly Health Systems Participant.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences.

Enhabit, Inc. (NYSEEHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024.

Enhabit, Inc. (NYSEEHAB) (the “Company”), a leading home health and hospice provider, today announced that the preliminary vote count of its proxy solicitor indicates that its stockholders have voted to elect eight of Enhabit’s director nominees at the 2024 Annual Meeting of Stockholders:

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today reminded stockholders to protect the value of their investment by voting ahead of the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) which will be held on July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the Annual Meeting.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that Institutional Shareholder Services (ISS) has recommended stockholders vote “FOR” a majority of Enhabit’s director nominees in connection with the Company’s Annual Meeting of Stockholders scheduled for July 25, 2024.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders scheduled for July 25, 2024. Stockholders of record, as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. The presentation can be found at investors.ehab.com/2024-annual-meeting/.

Enhabit, Inc. (NYSEEHAB), (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024 are entitled to vote at the 2024 Annual Meeting.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it was named as one of U.S. News & World Report’s 2024-2025 Best Companies to Work For in the South.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”) today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the “SEC”) in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the Leerink Partners Healthcare Crossroads Conference 2024.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced Enhabit’s Board of Directors (the “Board”) has concluded the Company’s strategic review process, announced in August 2023, which was overseen by the Board with assistance from its financial and legal advisors, Goldman Sachs and Sidley Austin, respectively. After evaluating a full range of strategic alternatives, including a potential sale, merger or other transaction, the Board unanimously determined that continuing to execute on the Company’s strategic plan as an independent, public company is in the best interests of the Company and its shareholders at this time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2024, on May 8, 2024, and host a webcast and conference call on May 9, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it has earned the 2024 Top Workplaces USA award issued by Energage.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2023, on March 6, 2024, and host a webcast and conference call on March 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2023.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today provided updates on the timing for release of its results for the third quarter ended Sept. 30, 2023, and certain other matters.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today announced that it has satisfied the conditions in its Tax Matters Agreement (“TMA”), dated June 30, 2022, with Encompass Health Corporation to conduct a review of strategic alternatives and has formally initiated such process. As part of this process, the board of directors will consider a wide range of options for the Company including, among other things, a potential sale, merger or other strategic transaction. Certain transactions involving the company remain subject to additional conditions in the TMA, including securing an additional tax opinion with respect to the specific transaction, satisfactory to Encompass Health in its sole and absolute discretion, that such proposed transaction would not jeopardize the tax-free treatment of the spin-off of Enhabit.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2023.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2023, on Aug. 9, 2023, and host a webcast and conference call on Aug. 10, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the Jefferies Healthcare Conference.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2023.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2023, on May 9, 2023, and host a webcast and conference call on May 10, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced it has been awarded the Age-Friendly Care at Home Certification from Community Health Accreditation Partner (CHAP). Enhabit is the first home health provider to receive the CHAP certification for its home health agencies in Petersburg, Virginia, and Clermont, Florida.

Enhabit, Inc. (NYSEEHAB) (“Enhabit” or the “Company”), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC (“Cruiser”) and Harbour Point Capital Management LP (“Harbour Point” ), which collectively own approximately 4.7% of the outstanding shares of Enhabit’s common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company’s board will expand temporarily to 13 directors.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in two upcoming investor conferences.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2022.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2022, on Feb. 14, 2023, and host a webcast and conference call on Feb. 15, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the 23rd Annual “New Ideas for the New Year” Investor Conference.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.’s home health agency located in Fort Myers, Fla.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the BofA Securities Home Care Conference 2022 on Dec. 5, 2022.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, announced today its recent placements in Fortune’s “30 Best Large Workplaces in Healthcare” awards as well as Modern Healthcare’s “Best Places to Work in Healthcare” awards series, highlighting Enhabit’s commitment to its people.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced its participation in the Credit Suisse 31st Annual Healthcare Conference in Palos Verdes, California on Nov. 8, 2022.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2022.

Enhabit, Inc. (NYSEEHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2022, after the market closes on Nov. 1, 2022, and host a webcast and conference call on Nov. 2, 2022. Individuals who would like to participate in the conference call should dial in 15 minutes before the scheduled start time.

Enhabit, Inc. (NYSEEHAB), a leading home health and hospice provider, announced today the acquisition of Caring Hearts Hospice, a locally owned and operated hospice agency in Texas. Effective Oct. 1, 2022, this acquisition adds four hospice locations to Enhabit’s existing presence in Texas, allowing Enhabit to expand its nationwide footprint.